Ikena Oncology Inc reports results for the quarter ended in September - Earnings Summary

ImageneBio

10/11/2021 14:32

* Ikena Oncology Inc  IKNA.OQ  reported a quarterly adjusted
loss of 40 cents​​ per share for the quarter ended in September.
The mean expectation of four analysts for the quarter was for a
loss of 42 cents per share.
* Revenue was $3.75 million​;  analysts expected $4.05 million. 
* Ikena Oncology Inc's reported EPS for the quarter was a loss
of 40 cents​.
* The mean earnings estimate of analysts had fallen by
about 3.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Ikena Oncology Inc shares had risen by 19.5% this quarter.
* The company reported a quarterly loss of $14.52 million.
* Wall Street's median 12-month price target for Ikena Oncology
Inc is $27.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 10 at 02:32 p.m.
 ​All figures in US dollars unless otherwise stated